• Citer

Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers

par Tré-Hardy, Marie ;Cupaiolo, Roberto;Papleux, Emmanuelle ;Wilmet, Alain;Horeanga, Alexandra ;Antoine-Moussiaux, Thomas ;Della Vecchia, Andrea;Beukinga, Ingrid ;Vekemans, Marc;Blairon, Laurent
Référence The Journal of infection
Publication Publié, 2021-10-01

Lettre à l'éditeur

• Accès en ligne
• Détails
• Statistiques

Titre:	Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers
Auteur:	Tré-Hardy, Marie; Cupaiolo, Roberto; Papleux, Emmanuelle; Wilmet, Alain; Horeanga, Alexandra; Antoine-Moussiaux, Thomas; Della Vecchia, Andrea; Beukinga, Ingrid; Vekemans, Marc; Blairon, Laurent
Informations sur la publication:	The Journal of infection
Statut de publication:	Publié, 2021-10-01
Sujet CREF:	Pathologie maladies infectieuses
Mots-clés:	COVID-19
	Immunogenicity, Reactogenicity, Safety, mRNA-1273 vaccine
	SARS-CoV-2
Note générale:	SCOPUS: le.j
Langue:	Anglais
Identificateurs:	urn:issn:0163-4453
	info:doi/10.1016/j.jinf.2021.03.025
	info:pii/S0163445321001584
	info:scp/85104969151
	info:pmid/33811939